Table 3.
Polyphenols | Animal Species | Target Sites | Antioxidant Factor | Oxidative Stress Parameters | Inflammation Parameters | Ref. |
---|---|---|---|---|---|---|
Curcumin | Sprague- Dawley rats |
Hippocampus Serum |
CUMS | ↓ NOx2; ↓ 4-HNE; ↓ MDA; ↑ CAT |
[150] | |
Curcumin | Rats | Brain | Intracerebroventricular injection of propanoic acid to induce autistic behavior | ↓ TBARS; ↑ CAT; ↑ SOD; ↑ GSH | [151] | |
Curcumin | Male Wistar rats | The cortex and hippocampus | Reserpine treated | ↓ MAO | [152] | |
Curcumin | Male mice | Hippocampus, frontal cortex, amygdala | Regular ICR | ↓ MAO-A | [153] | |
Curcumin | Male rats | Brain | LPS administration | ↓COX-2 | [154] | |
Curcumin | Female albino rats | Serum | OVX | ↓ MAO-B; ↑ tyrosine Hydroxylase; ↓ NO; ↑ TAC; ↓ MDA |
↓IL-1β; ↓IL-6 | [155] |
Curcumin | Male Swiss mice | Brain | CUMS | ↑ CAT | [156] | |
Chrysin | Mice | Brain | Male young and aged Swiss Albino mice were kept in groups during aging | ↑ SOD; ↑ CAT; ↑ GPX in PFC and hippocampus | [157] | |
Chrysin | Male rats | Heart | Induced acute cardiotoxicity triggered by doxorubicin | ↑ GHS; ↑ CAT; ↑ SOD | [158] | |
Chrysin | Male Swiss mice | Brain | The neurotoxicity elicited by aluminium chloride | ↓ LPO; ↑ SOD; ↑ CAT in cortex and hippocampus; ↓ ROS in neuronal SH-SY5Y and microglial THP-1 cells in vitro | [159] | |
Hypericin | Wistar rats | Brain | Chronic psychosocial stress | ↓BDNF | [160] | |
Dimethyl fumarate | Male Wistar rats | Testicular Serum |
CUMS | ↓ MDA; ↑ GSH; ↑ TAC | [45] | |
Dimethyl fumarate and resveratrol | Wistar rats | Brain Serum |
CUMS | ↓ MDA ↑ TAC; ↑ GSH |
↑BDNF | [161] |
Resveratrol | Male Wistar rats | Plasma | CUMS | ↑ TAC; ↑ GSH | ↑ TNF-α; ↑ IL-6; ↑ CRP | [162] |
Hesperidin | Male Sprague- Dawley rats |
Brain | CUMS | ↓ MDA; ↓ nitrite;↑ GSH; ↑ CAT, ↓ NOS; | ↓ TNF-α; ↑ IL-1β; ↓ COX-2 | [163] |
Baicalin | Male Sprague- Dawley rats |
Brain | CUMS | ↑ SOD; ↓ MDA; ↑ Bcl-2 protein; ↓ Bax | ↓ IL-1β; ↓ caspase-3 proteins; ↑ BDNF | [164] |
Catechins | Sprague- Dawley rats |
Brain | CUMS | ↑ CAT; ↑ SOD; ↑ GSH | [165] | |
Hesperidin | Male mice | Serum | LPS | ↓ IL-1β; ↓ IL-6; ↓ TNF-α | [166] | |
Quercetin | Male Swiss albino mice | Brain, plasma | CUMS | ↑ GSH; ↑ SOD;↑ CAT | ↓ IL-1β; ↓ TNF-α | [167] |
Quercetin | Swiss albino mice | Brain, plasma | CUS | ↑ total thiol; ↑ CAT; ↓ TBARS; ↓ NOS; | ↓ IL-1β; ↓ IL-6; ↓ TNF-α; ↓ COX-2 | [168] |
Quercetin | Male Sprague-Dawley rats | Serum | CUMS | ↑ SOD; ↑ CAT; ↑ GSH; ↑ GPX; ↓ MAO | ↓ IL-1β; ↓ TNF-α | [169] |
Quercetin | Male Wistar rats | Brain | CUMS | ↓ MDA; ↓ nitrite; ↑ GSH; ↑ SOD | ↓ TNF-α; ↓ IL-6; ↓ iNOS | [170] |
Ferulic acid | Male mice | Brain | Reserpine | ↑ SOD; ↑ GSH; ↓ nitrite; ↓ LPO | ↓ IL-1β; ↓ TNF-α | [171] |
Salvianolic acid B |
Male albino Wistar rats | Brain | CMS | ↑ CAT; ↑ SOD; ↑ GPX, ↓ MDA | ↓ IL-6; ↓ IL-1β; ↓ TNF-α; ↓ NLRP3 | [172] |
Resveratrol | Male Wistar rats | Plasma | CUMS | ↑ TAC; ↑ GSH | ↑ TNF-α; ↑ IL-Iβ; ↑ CRP | [162] |
Ginsenoside | Mice | Brain | Behavioral tests (forced swimming, tail suspension) | ↑ SOD | [173] | |
Apocynum venetum leaf extract | Wistar rats | Hippocampus, serum | CUMS | ↓ ROS; ↓ MDA; ↑ SOD; ↑ CAT; ↑GPX; |
↓ Bcl-2/Bax; ↑ BDNF | [174] |
Hemerocallis citrina Baroni | Sprague- Dawley rats | Brain | CUMS | ↓ MDA | ↑ BDNF | [175] |
Silybum marianum (silymarin) | Swiss albino mice | Brain | Acute restraint stress induced by immobilizing | ↓ MDA; ↑ SOD; ↑ CAT; ↑ GSH | [176] | |
Silybum marianum (silymarin) | Wistar rats | Brain | Olfactory bulbectomized technique | ↓ MDA | ↑ BDNF | [177] |
Resveratrol | Sprague- Dawley rats | Brain | CUMS | ↓ MDA; ↑ SOD; ↑ CAT; ↑ GSH | [178] | |
Jasminum sambac (Jasmine tea) | Sprague- Dawley rats | Brain | CUMS | ↑ GLP-1 | ↑ BDNF | [179] |
Tea polyphenols | Mice | Brain | CUMS | ↓ MDA; ↑ SOD; ↑ CAT; ↑ GSH | [180] | |
Okra seeds (catechin and quercetin derivatives) | Mice | Brain | Behavioral tests (open field, tail suspension, forced swimming, novelty suppressed feeding | ↓ MDA; ↑ TAC; ↑ SOD | [181] |
↑—increased concentration or activity compared to the treated group; ↓—decreased or inhibited concentration or activity compared to the treated group; 4-HNE—4-hydroxynonenal; Bcl-2—B-cell lymphoma 2; Bax—Bcl-2-associated X protein; BDNF—Brain-derived neurotrophic factor; CAT—catalase; COX-2—cyclooxygenase; CRP—C-reactive protein; CUMS—chronic unpredictable mild stress; CUS—chronic unpredictable stress; CMS—chronic mild stress; GLP-1—glucacon-like peptide 1; GSH—glutathione; GPX—glutathione peroxidase; IL-1β—interleukin 1β; IL-6—interleukin 6; iNOS—inducible nitric oxide synthase; LPS—lipopolysaccharide; MAO—monoamine oxidase; MAO–A—monoamine oxidase A; MAO-B—monoamine oxidase B; NOx—index of nitrite/nitrate; LPO—lipid peroxidation; MDA—malondialdehyde; NO—nitric oxide; PFC—prefrontal cortex; ROS—reactive oxygen species; SOD—superoxide dismutase; TBARS—thiobarbituric acid reactive substances; TAC—total antioxidant capacity; TNF-α—tumor necrosis factor. THP-1 monocytic cells; SH-SY5Y—the human neuroblastoma cell line; NLRP3—NOD-like receptor family, pyrin domain containing 3.